Linda-Gail Bekker MBChB, DTMH, DCH, FCP(SA) is a professor of Medicine and Chief Operating Officer of the Desmond Tutu HIV Foundation.

[10] The Desmond Tutu HIV Foundation, where Bekker serves as Chief Operating Officer, supports the wellbeing of people in South Africa's poorest communities.

[12] She developed a mobile health van, known as the Tutu tester, which offers screening for pregnancy, high blood pressure, diabetes, HIV/AIDS, TB and obesity.

[13][10] She is Director of the Desmund Tutu HIV Centre at the University of Cape Town, where she integrates best practise and evidence-based information about adolescent treatment and prevention in a robust platform.

[21] She gave the opening address at the International AIDS Society Conference in Paris, where she spoke about new prevention options such as Pre-exposure prophylaxis.

[31][32] No participants receiving twice-yearly lenacapavir acquired HIV infection was also reported in The New England Journal of Medicine article.

[33] Bekker was the co-lead investigator, along with Glenda Gray, of the Sisonke trial that aimed to give the health-care workers in South Africa early access to COVID vaccines.